EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5′ cap-modified mRNAs

Hirohisa Ohno, Sae Akamine, Megumi Mochizuki, Karin Hayashi, Shinichiro Akichika, Tsutomu Suzuki, Hirohide Saito iD

Nucleic Acids Research · 2023

DOI: 10.1093/nar/gkad019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Hirohisa Ohno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. Hauptthemen laut MEDLINE: RNA Caps, Vaccinia virus, Nucleotidyltransferases. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation, Sasakawa Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potential of synthetic mRNA as a genetic carrier has increased its application in scientific fields. Because the 5′ cap regulates the stability and translational activity of mRNAs, there are concerted efforts to search for and synthesize chemically-modified 5′ caps that improve the functionality of mRNA. Here, we report an easy and efficient method to synthesize functional mRNAs by modifying multiple 5′ cap analogs using a vaccinia virus-capping enzyme. We show that this enzyme can introduce a variety of GTP analogs to the 5′ end of RNA to generate 5′ cap-modified mRNAs that exhibit different translation levels. Notably, some of these modified mRNAs improve translation efficiency and can be conjugated to chemical structures, further increasing their functionality. Our versatile method to generate 5′ cap-modified mRNAs will provide useful tools for RNA therapeutics and biological research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA CapsVaccinia virusNucleotidyltransferasesProtein BiosynthesisRNA, MessengerMethyltransferasesMultienzyme ComplexesPhosphoric Monoester HydrolasesViral Proteins

Substanzen

RNA CapsRNA, MessengerNucleotidyltransferasescapping enzyme, vaccinia virusMethyltransferasesMultienzyme ComplexesPhosphoric Monoester HydrolasesViral Proteins

Autor:innen und Institutionen

  • Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
  • Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.
  • Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.

ORCID-Profile: Hirohide Saito

Förderung

  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • Sasakawa Scientific Research
  • Japan Science Society
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Japan Agency for Medical Research and Development
  • Research Center Network
  • iPS Cell Research Fund

Zitieren

APA

Ohno, H., Akamine, S., Mochizuki, M., Hayashi, K., Akichika, S., Suzuki, T., & Saito, H. (2023). Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5′ cap-modified mRNAs. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad019

Vancouver

Ohno H, Akamine S, Mochizuki M, Hayashi K, Akichika S, Suzuki T, et al. Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5′ cap-modified mRNAs. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad019

BibTeX
@article{Ohno2023,
  author = {Ohno, Hirohisa and Akamine, Sae and Mochizuki, Megumi and Hayashi, Karin and Akichika, Shinichiro and Suzuki, Tsutomu and Saito, Hirohide},
  title = {Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5′ cap-modified mRNAs},
  journal = {Nucleic Acids Research},
  year = {2023},
  doi = {10.1093/nar/gkad019}
}
Kostenlos starten →